ResMed Interest Income (Expense), Nonoperating increased by 54.6% to $12.29M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1449.4%, from $793.00K to $12.29M. Over 3 years (FY 2022 to FY 2025), Interest Income (Expense), Nonoperating shows an upward trend with a -43.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Lower net interest expense indicates reduced debt burden or improved interest rate management, while higher expense signals increased leverage or rising interest rates.
This represents the net interest expense incurred on corporate debt obligations, offset by interest income earned on cas...
Standardized across all capital-intensive industries as 'Net Interest Expense'.
other_income_expense_interest_income_expense_nonoperating_net| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$5.58M | -$5.58M | -$5.58M | -$5.58M | -$11.84M | -$11.84M | -$11.84M | -$11.84M | -$14.96M | -$13.81M | -$11.03M | -$5.92M | -$1.66M | -$775.00K | $793.00K | $5.76M | $8.79M | $7.95M | $12.29M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -112.3% | +0.0% | +0.0% | +0.0% | -26.3% | +7.7% | +20.1% | +46.3% | +71.9% | +53.3% | +202.3% | +626.0% | +52.7% | -9.6% | +54.6% |
| YoY Change | — | — | — | — | -112.3% | -112.3% | -112.3% | -112.3% | -26.3% | -16.5% | +6.9% | +50.0% | +88.9% | +94.4% | +107.2% | +197.2% | +629.4% | >999% | >999% |